<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>佰傲谷BioValley | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-29T16:43:06+08:00</updated>
  <subtitle>佰傲谷致力于打造一个垂直于生物制品领域的第三方平台。为生物制药企业提供品牌推广、技术咨询、项目交易、企业合作、人才培养等服务。为生物制药行业从业人员提供沟通交流、会议培训、工作求职、个人展示平台</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>【参会须知】下周相聚，第二届Bio-ONE生物工艺大会即将在沪召开!</title>
    <updated>2020-11-29T10:18:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/eDLwJ7p7em8mFgvUVmlsiw</id>
    <link href="https://mp.weixin.qq.com/s/eDLwJ7p7em8mFgvUVmlsiw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>招聘 | JD | 实习生/投资分析师/投资经理（生物医药/医疗健康方向）</title>
    <updated>2020-11-29T10:18:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/hc-wVyWMA9lDxVvynXl7Lw</id>
    <link href="https://mp.weixin.qq.com/s/hc-wVyWMA9lDxVvynXl7Lw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>靶点药讯37|纵览全球药物靶点动态</title>
    <updated>2020-11-28T09:20:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/qsDrymxsg6jBL7Yw9Z27Cg</id>
    <link href="https://mp.weixin.qq.com/s/qsDrymxsg6jBL7Yw9Z27Cg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>溶瘤病毒概况：病毒选择、作用机制、工艺改造、临床策略</title>
    <updated>2020-11-28T09:20:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/rn3rJ7owtUzi04cwNrdrlA</id>
    <link href="https://mp.weixin.qq.com/s/rn3rJ7owtUzi04cwNrdrlA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>下周五/六 | 华理天团领衔生物药工艺大会，疫情之下，如何顺利参会？</title>
    <updated>2020-11-28T09:20:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/q_RpmBoAsTwTNYfpcI6SRg</id>
    <link href="https://mp.weixin.qq.com/s/q_RpmBoAsTwTNYfpcI6SRg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅揭晓丨2020生物产业年度评选攀登榜</title>
    <updated>2020-11-27T12:08:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/kfIFyyv5uEdoqKM42m1lOw</id>
    <link href="https://mp.weixin.qq.com/s/kfIFyyv5uEdoqKM42m1lOw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国药锦奇携手FUJIFILM Irvine Scientific助力中国生物制药行业发展</title>
    <updated>2020-11-27T12:08:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/BuEQ97HWqZYsEo-NNze5Rw</id>
    <link href="https://mp.weixin.qq.com/s/BuEQ97HWqZYsEo-NNze5Rw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一次性使用技术在无菌灌装工艺中的应用</title>
    <updated>2020-11-27T12:08:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/RmKWxIPsgr9JoFFwXEoWzQ</id>
    <link href="https://mp.weixin.qq.com/s/RmKWxIPsgr9JoFFwXEoWzQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>下周五/六 | 华理天团领衔生物药工艺大会，疫情之下，如何顺利参会？</title>
    <updated>2020-11-27T12:08:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/F0pkGiVhr5nVfVGgBhH7xA</id>
    <link href="https://mp.weixin.qq.com/s/F0pkGiVhr5nVfVGgBhH7xA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>热点解读｜Claudin 18.2-下一个肿瘤免疫治疗 / 伴随诊断新热点</title>
    <updated>2020-11-26T11:40:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/s0FCYFwulJ27JLzdlTtyxg</id>
    <link href="https://mp.weixin.qq.com/s/s0FCYFwulJ27JLzdlTtyxg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>迭代上市的JAK抑制剂</title>
    <updated>2020-11-26T11:40:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/v9q8U4W2WOPqTj_vlTmvFQ</id>
    <link href="https://mp.weixin.qq.com/s/v9q8U4W2WOPqTj_vlTmvFQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球第三款GD2抗体获批上市，对抗儿童癌症之王</title>
    <updated>2020-11-26T11:40:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/UB36DDpdPqNtw6pNK8EPaA</id>
    <link href="https://mp.weixin.qq.com/s/UB36DDpdPqNtw6pNK8EPaA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>华理天团领衔生物药工艺大会，疫情之下，如何顺利参会？</title>
    <updated>2020-11-26T11:40:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/XBXdJ8G1S3asfvH6q5azyA</id>
    <link href="https://mp.weixin.qq.com/s/XBXdJ8G1S3asfvH6q5azyA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球第三款RNAi疗法获批，系首款PH1治疗药物</title>
    <updated>2020-11-25T12:33:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/33SqiV8Q-BplDl1gifZksw</id>
    <link href="https://mp.weixin.qq.com/s/33SqiV8Q-BplDl1gifZksw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>生物医药行业创新风口下，投资者如何选择？</title>
    <updated>2020-11-25T12:33:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/A1l67TNXGcvwyO9u_uQPQw</id>
    <link href="https://mp.weixin.qq.com/s/A1l67TNXGcvwyO9u_uQPQw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>及时止损？Genmab果断砍掉一款Ⅰ/Ⅱ期 ADC候选产品</title>
    <updated>2020-11-25T12:33:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/9ehFReiZ4TTPQekFfBd4GQ</id>
    <link href="https://mp.weixin.qq.com/s/9ehFReiZ4TTPQekFfBd4GQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第二届华理BIO-ONE大会最终议程，疫情之下，如何顺利参会？尽早安排！</title>
    <updated>2020-11-25T12:33:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/4xjd_rFm5mSFJslN-HHwMw</id>
    <link href="https://mp.weixin.qq.com/s/4xjd_rFm5mSFJslN-HHwMw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>实体瘤的突破，首个TCR疗法Ⅲ期临床试验成功</title>
    <updated>2020-11-24T12:15:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/eqFeDFB8Fg-eCoEZRQro3w</id>
    <link href="https://mp.weixin.qq.com/s/eqFeDFB8Fg-eCoEZRQro3w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 Think Big 十佳入选项目专访 | 泰尔康医药—共创多肽靶向药物的美好明天</title>
    <updated>2020-11-24T12:15:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/s9fDlgPpHzmJdiGU_23tpw</id>
    <link href="https://mp.weixin.qq.com/s/s9fDlgPpHzmJdiGU_23tpw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>善变的Th17，顽固的自免疾病</title>
    <updated>2020-11-24T12:15:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/I_LmnqCylyR3ZJx4wqL1DA</id>
    <link href="https://mp.weixin.qq.com/s/I_LmnqCylyR3ZJx4wqL1DA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>